Massive study aims to unlock Cancer's immune secrets

NCT ID NCT03958240

Recruiting now Knowledge-focused Sponsor: Institut Claudius Regaud Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study will collect blood and tumor samples from 1,100 people with various cancers, including head and neck, ovarian, cervical, lung, and brain cancers. Researchers want to learn how immune cells called T cells behave in these tumors. The goal is to better understand why some cancers respond to immunotherapy and others do not.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help researchers design better immunotherapies for several types of cancer.
What could go wrong: This is an observational study, not a treatment trial. It will not directly benefit participants and may not lead to new therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anal carcinoma anus neoplasm brain glioblastoma brain stem glioblastoma cervical cancer cervical intraepithelial neoplasia cervical intraepithelial neoplasia grade 2/3 glioblastoma glioma susceptibility 1 head and neck cancer Head and Neck Neoplasms neoplasm non-small cell lung carcinoma ovarian cancer Uterine Cervical Neoplasms uterine cervix carcinoma in situ

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANAL CANCER CERVICAL CANCER CERVICAL INTRAEPITHELIAL NEOPLASIA 3 GLIOBLASTOMA MULTIFORME OF BRAIN STEM HEAD AND NECK CANCER NON-SMALL CELL LUNG CANCER OVARIAN CANCER

Contacts and locations

Locations

Hopital Larrey
RECRUITING

Toulouse, 31059, France
Hopital Rangueil
RECRUITING

Toulouse, 31059, France
Institut Universitaire du Cancer Toulouse - Oncopole
RECRUITING

Toulouse, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.